VERU INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that VERU INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Sep 30, 2023 | $16.30M | Apr 1, 2024 |
| FY2023 | Sep 30, 2022 | $39.35M | Apr 1, 2024 |
| FY2022 | Sep 30, 2021 | $61.26M | Dec 5, 2022 |
| FY2021 | Sep 30, 2020 | $42.59M | Dec 2, 2021 |
| FY2020 | Sep 30, 2019 | $31.80M | Dec 10, 2020 |
| FY2019 | Sep 30, 2018 | $15.86M | Dec 12, 2019 |
| FY2018 | Sep 30, 2017 | $13.66M | Dec 13, 2018 |
| FY2014 | Sep 30, 2014 | $24.49M | Dec 2, 2014 |
| FY2014 | Sep 30, 2013 | $31.46M | Dec 2, 2014 |
| FY2014 | Sep 30, 2012 | $35.03M | Dec 2, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2024 | $16.89M | Dec 16, 2024 |
| FY2024 | Sep 30, 2023 | $16.30M | Dec 16, 2024 |
| FY2023 | Sep 30, 2022 | $39.35M | Apr 1, 2024 |
| FY2022 | Sep 30, 2021 | $61.26M | Dec 5, 2022 |
| FY2021 | Sep 30, 2020 | $42.59M | Dec 2, 2021 |
| FY2020 | Sep 30, 2019 | $31.80M | Dec 10, 2020 |
| FY2019 | Sep 30, 2018 | $15.86M | Dec 12, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Sep 30, 2017 | $3.69M | Jan 2, 2018 |
| FY2017 | Jun 30, 2017 | $4.31M | Jan 2, 2018 |
| FY2017 | Mar 31, 2017 | $2.41M | Jan 2, 2018 |
| FY2017 | Dec 31, 2016 | $3.24M | Jan 2, 2018 |
| FY2017 | Sep 30, 2016 | $3.56M | Jan 2, 2018 |
| FY2017 | Jun 30, 2016 | $5.56M | Jan 2, 2018 |
| FY2017 | Mar 31, 2016 | $4.77M | Jan 2, 2018 |
| FY2017 | Dec 31, 2015 | $8.23M | Jan 2, 2018 |
| FY2016 | Sep 30, 2015 | $7.15M | Dec 12, 2016 |
| FY2016 | Jun 30, 2015 | $7.81M | Dec 12, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2024 | $5.85M | Dec 16, 2024 |
| FY2024 | Sep 30, 2023 | $7.57M | Dec 16, 2024 |
| FY2023 | Sep 30, 2022 | $30.59M | Apr 1, 2024 |
| FY2022 | Sep 30, 2021 | $47.93M | Dec 5, 2022 |
| FY2021 | Sep 30, 2020 | $30.79M | Dec 2, 2021 |
| FY2020 | Sep 30, 2019 | $21.66M | Dec 10, 2020 |
| FY2019 | Sep 30, 2018 | $8.77M | Dec 12, 2019 |
| FY2017 | Sep 30, 2017 | $1.79M | Jan 2, 2018 |
| FY2017 | Jun 30, 2017 | $2.29M | Jan 2, 2018 |
| FY2017 | Mar 31, 2017 | $1.28M | Jan 2, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($22.73M) | Dec 17, 2025 |
| FY2025 | Sep 30, 2024 | ($37.80M) | Dec 17, 2025 |
| FY2024 | Sep 30, 2023 | ($93.15M) | Dec 16, 2024 |
| FY2023 | Jun 30, 2023 | ($12.52M) | Apr 1, 2024 |
| FY2023 | Mar 31, 2023 | ($33.79M) | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | ($38.71M) | Apr 1, 2024 |
| FY2023 | Sep 30, 2022 | ($84.04M) | Apr 1, 2024 |
| FY2022 | Sep 30, 2021 | $7.39M | Dec 5, 2022 |
| FY2021 | Sep 30, 2020 | ($18.97M) | Dec 2, 2021 |
| FY2020 | Sep 30, 2019 | ($12.02M) | Dec 10, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($24.75M) | Dec 17, 2025 |
| FY2025 | Sep 30, 2024 | ($36.17M) | Dec 17, 2025 |
| FY2024 | Sep 30, 2023 | ($93.78M) | Dec 16, 2024 |
| FY2023 | Jun 30, 2023 | ($13.74M) | Apr 1, 2024 |
| FY2023 | Mar 31, 2023 | ($34.41M) | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | ($37.45M) | Apr 1, 2024 |
| FY2023 | Sep 30, 2022 | ($83.49M) | Apr 1, 2024 |
| FY2022 | Sep 30, 2021 | $12.97M | Dec 5, 2022 |
| FY2021 | Sep 30, 2020 | ($14.75M) | Dec 2, 2021 |
| FY2020 | Sep 30, 2019 | ($6.44M) | Dec 10, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $15.59M | Dec 17, 2025 |
| FY2025 | Sep 30, 2024 | $12.78M | Dec 17, 2025 |
| FY2024 | Sep 30, 2023 | $51.20M | Dec 16, 2024 |
| FY2023 | Jun 30, 2023 | $8.79M | Apr 1, 2024 |
| FY2023 | Mar 31, 2023 | $17.86M | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | $20.61M | Apr 1, 2024 |
| FY2023 | Sep 30, 2022 | $70.91M | Apr 1, 2024 |
| FY2022 | Sep 30, 2021 | $32.69M | Dec 5, 2022 |
| FY2021 | Sep 30, 2020 | $16.94M | Dec 2, 2021 |
| FY2020 | Sep 30, 2019 | $13.74M | Dec 10, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2024 | $31.18M | Dec 16, 2024 |
| FY2024 | Sep 30, 2023 | $48.06M | Dec 16, 2024 |
| FY2023 | Sep 30, 2022 | $43.18M | Apr 1, 2024 |
| FY2022 | Sep 30, 2021 | $20.67M | Dec 5, 2022 |
| FY2021 | Sep 30, 2020 | $14.50M | Dec 2, 2021 |
| FY2020 | Sep 30, 2019 | $14.35M | Dec 10, 2020 |
| FY2019 | Sep 30, 2018 | $14.81M | Dec 12, 2019 |
| FY2018 | Sep 30, 2017 | $11.50M | Dec 13, 2018 |
| FY2017 | Sep 30, 2016 | $8.66M | Jan 2, 2018 |
| FY2017 | Sep 30, 2015 | $12.13M | Jan 2, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($30.04M) | Dec 17, 2025 |
| FY2025 | Sep 30, 2024 | ($21.68M) | Dec 17, 2025 |
| FY2024 | Sep 30, 2023 | ($88.01M) | Dec 16, 2024 |
| FY2023 | Sep 30, 2022 | ($47.51M) | Apr 1, 2024 |
| FY2022 | Sep 30, 2021 | ($15.57M) | Dec 5, 2022 |
| FY2021 | Sep 30, 2020 | ($1.93M) | Dec 2, 2021 |
| FY2020 | Sep 30, 2019 | ($5.49M) | Dec 10, 2020 |
| FY2019 | Sep 30, 2018 | ($11.55M) | Dec 12, 2019 |
| FY2018 | Sep 30, 2017 | $982.9K | Dec 13, 2018 |
| FY2013 | Sep 30, 2013 | $11.79M | Dec 3, 2013 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.1K | Dec 17, 2025 |
| FY2025 | Sep 30, 2024 | $158.3K | Dec 17, 2025 |
| FY2024 | Sep 30, 2023 | $665.7K | Dec 16, 2024 |
| FY2023 | Sep 30, 2022 | $733.1K | Apr 1, 2024 |
| FY2022 | Sep 30, 2021 | $376.6K | Dec 5, 2022 |
| FY2021 | Sep 30, 2020 | $105.8K | Dec 2, 2021 |
| FY2020 | Sep 30, 2019 | $108.5K | Dec 10, 2020 |
| FY2019 | Sep 30, 2018 | $50.7K | Dec 12, 2019 |
| FY2018 | Sep 30, 2017 | $133.5K | Dec 13, 2018 |
| FY2017 | Sep 30, 2016 | $6.4K | Jan 2, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $29.84M | Dec 17, 2025 |
| FY2025 | Sep 30, 2024 | $60.42M | Dec 17, 2025 |
| FY2024 | Sep 30, 2023 | $50.02M | Dec 16, 2024 |
| FY2023 | Jun 30, 2023 | $60.20M | Apr 1, 2024 |
| FY2023 | Mar 31, 2023 | $70.34M | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | $101.27M | Apr 1, 2024 |
| FY2023 | Sep 30, 2022 | $135.36M | Apr 1, 2024 |
| FY2022 | Sep 30, 2021 | $178.15M | Dec 5, 2022 |
| FY2021 | Sep 30, 2020 | $51.54M | Dec 2, 2021 |
| FY2020 | Sep 30, 2019 | $53.63M | Dec 10, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $11.50M | Dec 17, 2025 |
| FY2025 | Sep 30, 2024 | $28.10M | Dec 17, 2025 |
| FY2024 | Sep 30, 2023 | $30.34M | Dec 16, 2024 |
| FY2023 | Jun 30, 2023 | $39.56M | Apr 1, 2024 |
| FY2023 | Mar 31, 2023 | $48.53M | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | $52.08M | Apr 1, 2024 |
| FY2023 | Sep 30, 2022 | $52.56M | Apr 1, 2024 |
| FY2022 | Sep 30, 2021 | $25.85M | Dec 5, 2022 |
| FY2021 | Sep 30, 2020 | $21.43M | Dec 2, 2021 |
| FY2020 | Sep 30, 2019 | $21.30M | Dec 10, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $18.33M | Dec 17, 2025 |
| FY2025 | Sep 30, 2024 | $32.32M | Dec 17, 2025 |
| FY2025 | Sep 30, 2023 | $19.68M | Dec 17, 2025 |
| FY2023 | Jun 30, 2023 | $20.65M | Apr 1, 2024 |
| FY2023 | Mar 31, 2023 | $21.81M | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | $49.19M | Apr 1, 2024 |
| FY2024 | Sep 30, 2022 | $82.80M | Dec 16, 2024 |
| FY2023 | Sep 30, 2021 | $154.52M | Apr 1, 2024 |
| FY2022 | Sep 30, 2020 | $30.11M | Dec 5, 2022 |
| FY2021 | Sep 30, 2019 | $32.33M | Dec 2, 2021 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $6.88M | Dec 17, 2025 |
| FY2025 | Sep 30, 2024 | $6.88M | Dec 17, 2025 |
| FY2024 | Sep 30, 2023 | $6.88M | Dec 16, 2024 |
| FY2023 | Sep 30, 2022 | $6.88M | Apr 1, 2024 |
| FY2022 | Sep 30, 2021 | $6.88M | Dec 5, 2022 |
| FY2021 | Sep 30, 2020 | $6.88M | Dec 2, 2021 |
| FY2020 | Sep 30, 2019 | $6.88M | Dec 10, 2020 |
| FY2019 | Sep 30, 2018 | $6.88M | Dec 12, 2019 |
| FY2018 | Sep 30, 2017 | $6.88M | Dec 13, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($317.30M) | Dec 17, 2025 |
| FY2025 | Sep 30, 2024 | ($294.57M) | Dec 17, 2025 |
| FY2024 | Sep 30, 2023 | ($256.77M) | Dec 16, 2024 |
| FY2023 | Jun 30, 2023 | ($248.64M) | Apr 1, 2024 |
| FY2023 | Mar 31, 2023 | ($236.11M) | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | ($202.32M) | Apr 1, 2024 |
| FY2023 | Sep 30, 2022 | ($163.62M) | Apr 1, 2024 |
| FY2022 | Sep 30, 2021 | ($81.80M) | Dec 5, 2022 |
| FY2021 | Sep 30, 2020 | ($89.19M) | Dec 2, 2021 |
| FY2020 | Sep 30, 2019 | ($70.22M) | Dec 10, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $15.79M | Dec 17, 2025 |
| FY2025 | Sep 30, 2024 | $24.92M | Dec 17, 2025 |
| FY2024 | Sep 30, 2023 | $9.63M | Dec 16, 2024 |
| FY2015 | Sep 30, 2015 | $4.11M | Dec 2, 2015 |
| FY2015 | Sep 30, 2014 | $5.80M | Dec 2, 2015 |
| FY2015 | Sep 30, 2013 | $8.92M | Dec 2, 2015 |
| FY2015 | Sep 30, 2012 | $5.30M | Dec 2, 2015 |
| FY2014 | Sep 30, 2011 | $4.25M | Dec 2, 2014 |
| FY2013 | Sep 30, 2010 | $2.92M | Dec 3, 2013 |
| FY2012 | Sep 30, 2009 | $2.81M | Dec 4, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | (1) | Dec 17, 2025 |
| FY2025 | Sep 30, 2024 | (2) | Dec 17, 2025 |
| FY2024 | Sep 30, 2023 | (1) | Dec 16, 2024 |
| FY2023 | Jun 30, 2023 | 0 | Apr 1, 2024 |
| FY2023 | Mar 31, 2023 | 0 | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2023 | Sep 30, 2022 | (1) | Apr 1, 2024 |
| FY2022 | Sep 30, 2021 | 0 | Dec 5, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Dec 2, 2021 |
| FY2017 | Sep 30, 2017 | 0 | Jan 2, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Sep 30, 2023 | (1) | Apr 1, 2024 |
| FY2023 | Jun 30, 2023 | 0 | Apr 1, 2024 |
| FY2023 | Mar 31, 2023 | 0 | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2023 | Sep 30, 2022 | (1) | Apr 1, 2024 |
| FY2022 | Sep 30, 2021 | 0 | Dec 5, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Dec 2, 2021 |
| FY2017 | Sep 30, 2017 | 0 | Jan 2, 2018 |
| FY2017 | Jun 30, 2017 | 0 | Jan 2, 2018 |
| FY2017 | Mar 31, 2017 | 0 | Jan 2, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 14.65M | Dec 17, 2025 |
| FY2025 | Sep 30, 2024 | 14.64M | Dec 17, 2025 |
| FY2024 | Sep 30, 2023 | 91.78M | Dec 16, 2024 |
| FY2023 | Sep 30, 2022 | 80.51M | Apr 1, 2024 |
| FY2022 | Sep 30, 2021 | 79.97M | Dec 5, 2022 |
| FY2021 | Sep 30, 2020 | 69.86M | Dec 2, 2021 |
| FY2020 | Sep 30, 2019 | 65.04M | Dec 10, 2020 |
| FY2019 | Sep 30, 2018 | 55.28M | Dec 12, 2019 |
| FY2018 | Sep 30, 2017 | 53.21M | Dec 13, 2018 |
| FY2017 | Sep 30, 2016 | 29.09M | Jan 2, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Sep 30, 2015 | $5.3K | Jan 2, 2018 |
| FY2016 | Sep 30, 2014 | $6.07M | Dec 12, 2016 |
| FY2013 | Nov 6, 2013 | $2.00M | Dec 3, 2013 |
| FY2015 | Sep 30, 2013 | $7.47M | Dec 2, 2015 |
| FY2012 | Nov 7, 2012 | $1.70M | Dec 4, 2012 |
| FY2014 | Sep 30, 2012 | $6.19M | Dec 2, 2014 |
| FY2013 | Sep 30, 2011 | $5.55M | Dec 3, 2013 |
| FY2012 | Sep 30, 2010 | $4.12M | Dec 4, 2012 |